From the proteomic analysis, we hypothesised that elevated IL-18BP would reduce the pro-inflammatory effects of IL-18 and that this would lead to positive association of IL-18BP with muscle mass or strength in individuals with sarcopenia. The gene discussed is IL18; the disease is sarcopenia.